[HTML][HTML] CAFs orchestrates tumor immune microenvironment—A new target in cancer therapy?
C Zhang, Y Fei, H Wang, S Hu, C Liu, R Hu… - Frontiers in …, 2023 - frontiersin.org
Cancer immunotherapy has opened a new landscape in cancer treatment, however, the
poor specificity and resistance of most targeted therapeutics have limited their therapeutic …
poor specificity and resistance of most targeted therapeutics have limited their therapeutic …
[HTML][HTML] CAFs orchestrates tumor immune microenvironment—A new target in cancer therapy?
C Zhang, Y Fei, H Wang, S Hu, C Liu… - Frontiers in …, 2023 - ncbi.nlm.nih.gov
Cancer immunotherapy has opened a new landscape in cancer treatment, however, the
poor specificity and resistance of most targeted therapeutics have limited their therapeutic …
poor specificity and resistance of most targeted therapeutics have limited their therapeutic …
[引用][C] CAFs orchestrates tumor immune microenvironment—A new target in cancer therapy?
C Zhang, Y Fei, Q Du, X Pan, J Yang, B Zhao… - Frontiers in …, 2023 - Elsevier
CAFs orchestrates tumor immune microenvironment—A new target in cancer therapy?
C Zhang, Y Fei, H Wang, S Hu, C Liu… - Frontiers in …, 2023 - europepmc.org
Cancer immunotherapy has opened a new landscape in cancer treatment, however, the
poor specificity and resistance of most targeted therapeutics have limited their therapeutic …
poor specificity and resistance of most targeted therapeutics have limited their therapeutic …
CAFs orchestrates tumor immune microenvironment-A new target in cancer therapy?
C Zhang, Y Fei, H Wang, S Hu… - Frontiers in …, 2023 - pubmed.ncbi.nlm.nih.gov
Cancer immunotherapy has opened a new landscape in cancer treatment, however, the
poor specificity and resistance of most targeted therapeutics have limited their therapeutic …
poor specificity and resistance of most targeted therapeutics have limited their therapeutic …